0001562180-24-000466.txt : 20240116
0001562180-24-000466.hdr.sgml : 20240116
20240116180137
ACCESSION NUMBER: 0001562180-24-000466
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240111
FILED AS OF DATE: 20240116
DATE AS OF CHANGE: 20240116
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Liu Ye
CENTRAL INDEX KEY: 0001840407
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51122
FILM NUMBER: 24536286
MAIL ADDRESS:
STREET 1: ROOM 502-I, WANT WANT PLAZA
STREET 2: NO. 211 SHIMEN YI ROAD
CITY: SHANGHAI
STATE: F4
ZIP: 200041
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: EyePoint Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001314102
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 262774444
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 480 PLEASANT STREET
STREET 2: SUITE B300
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: 617-926-5000
MAIL ADDRESS:
STREET 1: 480 PLEASANT STREET
STREET 2: SUITE B300
CITY: WATERTOWN
STATE: MA
ZIP: 02472
FORMER COMPANY:
FORMER CONFORMED NAME: pSivida Corp.
DATE OF NAME CHANGE: 20080619
FORMER COMPANY:
FORMER CONFORMED NAME: pSivida LTD
DATE OF NAME CHANGE: 20050111
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0508
4
2024-01-11
false
0001314102
EyePoint Pharmaceuticals, Inc.
EYPT
0001840407
Liu Ye
56F, ONE MUSEUM PLACE, 669 XIN ZHA ROAD
JING'AN DISTRICT
SHANGHAI
200041
true
false
false
false
false
Common Stock, $0.001 par value
2024-01-11
4
S
false
1910500.00
19.45
D
100221.00
I
Ocumension Therapeutics
The shares are held by Ocumension Therapeutics. The reporting person is Chief Executive Officer and a Director of Ocumension Therapeutics. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
/s/ Ron Honig, Attorney-in-Fact
2024-01-16